Drug promotional literature
Drug promotional literature (DPL) consists of pamphlets or brochures printed by pharmaceutical companies in order to promote the sale of their products. As such, DPLs represent a major marketing technique.
Due to their concise nature, busy medical practitioners may sometimes rely on DPLs as the primary sources of drug information: DPLs can be highly informative when they provide the authentic information in a nutshell, as long as they have been critically analysed and reviewed; if not, they can be misleading.
In addition, pharmaceutical companies have to follow certain ethical guidelines at the national and international level for drug promotional activities to ensure better health care through the rational use of medicines: for instance, the World Health Organisation (WHO) states that “all promotion-making claims concerning medicinal drugs should be reliable, accurate, truthful, informative, balanced, up to date, capable of substantiation and in good taste”.
Unfortunately, physicians may be influenced by extensive marketing and may hastily prescribe new products without confirming the validity of the claims, which can in turn result in possible detrimental health-related consequences, e.g. failure of treatment from the use of inappropriate drugs, undesirable/adverse effects, rise in antibiotic-resistant microorganisms or an increase in the national health care expenditure.
Because DPLs influence the prescribing behaviour of medical practitioners, they have to be critically analysed for their content to prevent irrational prescribing patterns. Medical practitioners should therefore play a significant role in the critical evaluation of the information provided in a DPL before considering it as a scientific source of information and forward more complaints about such non compliant companies to regulatory authorities.
Thus, ethical promotion of drugs and their rational prescription is possible with the combined efforts of medical practitioners, pharmaceutical companies and regulatory bodies. In turn, these efforts will ensure that promotional literature is not just a marketing strategy but also a useful, up to date and accurate source of drug information.
Zorana Stanko, MA / Professional Medical Translator
Lašćinska cesta 40
Planinska ulica 13/2
Office: +385 1 5588 297
Pharmacovigilance: +385 1 5588 297
Clinical trials: +385 1 5614 330
Registration: +385 1 242 0873
Marketing: +385 1 2420 890
Fax: +385 1 2420 860
Tel: +385 1 5588 297
Full company name
Short company name
Marti Farm Ltd. Trade and Services
Marti Farm Ltd.
Lašćinska cesta 40, HR-10000 Zagreb
Planinska ulica 13/2, HR-10000 Zagreb
a limited liability company
Commercial Court of Zagreb
HRK 20,000.00 (paid in its entirety)
Martina Diminić Smetiško, director of the
company (Representing the company
individually and independently, Responsible
person for data protection)
HR3623600001102197724 (Zagrebačka banka)
HR4324020061100628669 (Erste banka)
Full company name: Marti Farm Ltd. Trade and Services
Short company name: Marti Farm Ltd.
Headquarters: Lašćinska cesta 40, HR-10000 Zagreb
Office: Planinska ulica 13/2, HR-10000 Zagreb
Legal form: a limited liability company
Court register: Commercial Court of Zagreb
Registration number: 080751121
Share capital: HRK 20,000.00 (paid in its entirety)
Authorized representative: Martina Diminić Smetiško, director of the company (Representing the company individually and independently, Responsible person for data protection)
Bank account: HR3623600001102197724 (Zagrebačka banka), HR4324020061100628669 (Erste banka)